Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Abhishek A, Doherty M. Pathophysiology of articular chondrocalcinosis--role of ANKH. Nat Rev Rheumatol. 2011;7(2):96–104.
Abhishek A, Doherty S, Maciewicz R, Muir K, Zhang W, Doherty M. Chondrocalcinosis is common in the absence of knee involvement. Arthritis Res Ther. 2012;14(5):R205.
Abhishek A, Doherty S, Maciewicz R, et al. The association between ANKH promoter polymorphism and chondrocalcinosis is independent of age and osteoarthritis: results of a case–control study. Arthritis Res Ther. 2014;16:R25.
Andres M, Sivera F, Pascual E. Methotrexate is an option for patients with refractory calcium pyrophosphate crystal arthritis. J Clin Rheumatol. 2012;18(5):234–6.
Andrés M, Vela P, Jovaní V, Pascual E. Most needle-shaped calcium pyrophosphate crystals lack birefringence. Rheumatology (Oxford). 2019;58(6):1095–8.
Announ N, Guerne PA. Treating difficult crystal pyrophosphate dihydrate deposition disease. Curr Rheumatol Rep. 2008;10(3):228–34.
Baldwin CT, Farrer LA, Adair R, Dharmavaram R, Jimenez S, Anderson L. Linkage of early-onset osteoarthritis and chondrocalcinosis to human chromosome 8q. Am J Hum Genet. 1995;56(3):692–7.
Boumans D, et al. The added value of centrifugation for monosodium urate and calcium pyrophosphate crystal detection. Clin Rheumatol. 2017;36:1599–605.
Chiba D, Tsuda E, Sasaki E, et al. Low prevalence of knee chondrocalcinosis and its catabolic association with serum matrix metalloproteinase 3: a rural Japanese population study. Int J Rheum Dis. 2017;21:2011–8.
Conti F, et al. Hypophosphatasia: clinical manifestation and burden of disease in adults. Clin Cases Miner Bone Metab. 2017;14(2):230–4.
Crawford R, Puddle B, Hunt N, et al. Deposition of calcium pyrophosphate in tissue after revision arthroplasty of the hip. J Bone Joint Surg Br. 1999;81(3):552–4.
Dieppe P, Crocker P, Corke C, et al. Synovial fluid crystals. Quarter J Med. 1979;48:533–55.
Doaré E, Robin F, Racapé H, Le Mélédo G, Orione C, Guggenbuhl P, Goupille P, Gervais E, Dernis E, Bouvard B, Marhadour T, Coiffier G, Saraux A. Features and outcomes of microcrystalline arthritis treated by biologics: a retrospective study. Rheumatol Ther. 2021;8(3):1241–53. https://doi.org/10.1007/s40744-021-00335-7. Epub ahead of print. PMID: 34218418
Dumusc A, So A. Answer to Cipolletta et al. “Treatment of acute CPP crystal arthritis: what are we missing?”. Joint Bone Spine. 2021;88:105217.
Ea HK, et al. Calcium pyrophosphate dihydrate crystal deposition in gouty tophi. Arthritis Rheum. 2021;73(2):324–9.
Finckh A, Mc Carthy GM, Madigan A, et al. Methotrexate in chronic-recurrent calcium pyrophosphate deposition disease: no significant effect in a randomized crossover trial. Arthritis Res Ther. 2014;16(5):458.
Fisseler-Eckhoff A, Muller KM. Arthroscopy and chondrocalcinosis. Arthroscopy. 1992;8:98–104.
Galvez J, Saiz E, Linares L, et al. Delayed examination of synovial fluid by ordinary and polarized light microscopy to detect and identify crystals. Ann Rheum Dis. 2002;61:444–7.
Gerster J, Varisco P, Kern J, et al. CPPD crystal deposition disease in patients with rheumatoid arthritis. Clin Rheumatol. 2006;25:468–9.
Haikal A, Everist BM, Jetanalin P, Maz M. Cervical CT-dependent diagnosis of crowned dens syndrome in calcium pyrophosphate dihydrate crystal deposition disease. Am J Med. 2020;133(2):e32–7.
Harato K, Yoshida H. Pseudogout in the early postoperative period after total knee arthroplasty. J Arthroplast. 2013;28(2):374.e9–374.e11.
Hearn P, Russell R, Elliott J, et al. Formation products of calcium pyrophosphate crystals in vitro and the effect of iron salts. Clin Sci. 1978;54:29P.
Hirose CB, Wright RW. Calcium pyrophosphate dihydrate deposition disease (pseudogout) after total knee arthroplasty. J Arthroplast. 2007;22(2):273–6.
Holt G, Vass C, Kumar CS. Acute crystal arthritis mimicking infection after total knee arthroplasty. BMJ. 2005;331(7528):1322–3.
Hughes AE, McGibbon D, Woodward E, Dixey J, Doherty M. Localisation of a gene for chondrocalcinosis to chromosome 5p. Hum Mol Genet. 1995;4(7):1225–8.
Ivorra J, Rosas J, Pascual E. Most calcium pyrophosphate crystals appear as non-birefringent. Ann Rheum Dis. 1999;58(9):582–4.
Kleiber Balderrama C, Rosenthal AK, Lans D, Singh JA, Bartels CM. Calcium pyrophosphate deposition disease and associated medical comorbidities: a National Cross-Sectional Study of US veterans. Arthritis Care Res (Hoboken). 2017;69(9):1400–6.
Latourte A, Ea HK, Frazier A, et al. Tocilizumab in symptomatic calcium pyrophosphate deposition disease: a pilot study. Ann Rheum Dis. 2020;79(8):1126–8.
Martinez-Sanchis A, Pascual E. Intracellular and extracellular CPPD crystals are a regular feature in synovial fluid from uninflamed joints of patients with CPPD related arthropathy. Ann Rheum Dis. 2005;64:1769–72.
McCarty DJ. Diagnostic mimicry in arthritis: patterns of joint involvement associated with calcium pyrophosphate dihydrate crystal deposits. Ann Rheum Dis. 1975;25:804–9.
Mitrovic D, Stankovic A, Iriarte-Borda O, et al. The prevalence of chondrocalcinosis in the human knee joint. An autopsy survey. J Rheumatol. 1988;15:633–41.
Mitton-Fitzgerald E, Gohr CM, Williams CJ, Ortiz A, Mbalaviele G, Rosenthal AK. The TNFRSF11B mutation associated with calcium pyrophosphate deposition disease results in ineffective osteoclast suppression. Rheumatol. 2021;73(8):1543–9. https://doi.org/10.1002/art.41678.
Moltó A, Ea HK, Richette P, Bardin T, Lioté F. Efficacy of anakinra for refractory acute calcium pyrophosphate crystal arthritis. Joint Bone Spine. 2012;79(6):621–3.
Moshrif A, Laredo JD, Bassiouni H, Abdelkareem M, Richette P, Rigon MR, Bardin T. Spinal involvement with calcium pyrophosphate deposition disease in an academic rheumatology center: a series of 37 patients. Semin Arthritis Rheum. 2019;48(6):1113–26.
O'Duffy J. Clinical studies of acute pseudogout attacks. Comments on prevalence, predisposition and treatment. Arthritis Rheum. 1976;19(Suppl):349–52.
Ottaviani S, Brunier L, Sibilia J, Maurier F, Ardizzone M, Wendling D, Gill G, Palazzo E, Meyer O, Dieudé P. Efficacy of anakinra in calcium pyrophosphate crystal-induced arthritis: a report of 16 cases and review of the literature. Joint Bone Spine. 2013;80(2):178–82.
Parperis K, Papachristodoulou E, Kakoullis L, Rosenthal AK. Management of calcium pyrophosphate crystal deposition disease: a systematic review. Semin Arthritis Rheum. 2021;51(1):84–94.
Pascual E, Tovar J, Ruiz MT. The ordinary light microscope: an appropriate tool for provisional detection and identification of crystals in synovial fluid. Ann Rheum Dis. 1989;48(12):983–5.
Quilis N, Andrés M, Vela P, Pascual E. Interleukin-6 pathway blockade as an option for managing refractory cases of crystal arthritis: two cases report. Joint Bone Spine. 2018;85(3):377–8.
Rosenthal AK, Ryan LM. Calcium pyrophosphate deposition disease. N Engl J Med. 2016;374(26):2575–84.
Rothschild B, Yakubov LE. Prospective 6-month, double-blind trial of hydroxychloroquine treatment of CPPD. Compr Ther. 1997;23(5):327–31.
Sabchyshyn V, Konon I, Ryan LM, Rosenthal AK. Concurrence of rheumatoid arthritis and calcium pyrophosphate deposition disease: A case collection and review of the literature. Semin Arthritis Rheum. 2018;48(1):9–11. https://doi.org/10.1016/j.semarthrit.2017.11.009. Epub 2017 Dec 2. PMID: 29338885; PMCID: PMC6240440.
Sonsale PD, Philipson MR. Pseudogout after total knee arthroplasty. J Arthroplast. 2007;22(2):271–2.
Thomas M, Forien M, Palazzo E, Dieudé P, Ottaviani S. Efficacy and tolerance of anakinra in acute calcium pyrophosphate crystal arthritis: a retrospective study of 33 cases. Clin Rheumatol. 2019;38(2):425–30.
Williams CJ, Qazi U, Bernstein M, et al. Mutations in osteoprotegerin account for the CCAL1 locus in calcium pyrophosphate deposition disease. Osteoarthr Cartil. 2018;26(6):797–806.
Yates KA, Yoshida K, Xu C, et al. Acute calcium pyrophosphate crystal arthritis flare rate and risk factors for recurrence. J Rheumatol. 2020;47(8):1261–6.
Younis AA. Crowned dens syndrome as a cause of acute neck pain: a case report and review of the literature. Mediterr J Rheumatol. 2017;28(2):101–5.
Yuan S, Bien C, Wener M, et al. Repeat examination of synovial fluid for crystals: is it useful? Clin Chem. 2003;49:1562–3.
Zaka R, Williams CJ. Role of the progressive ankylosis gene in cartilage mineralization. Curr Opin Rheumatol. 2006;18:181–6.
Zell M, Zhang D, FitzGerald J. Diagnostic advances in synovial fluid analysis and radiographic identification for crystalline arthritis. Curr Opin Rheumatol. 2019;31(2):134–43.
Zhang W, Doherty M, Bardin T, et al. European league against rheumatism recommendations for calcium pyrophosphate deposition. Part I: terminology and diagnosis. Ann Rheum Dis. 2011a;70(4):563–70.
Zhang W, Doherty M, Pascual E, et al. EULAR recommendations for calcium pyrophosphate deposition. Part II: management. Ann Rheum Dis. 2011b;70(4):571–5.
Zhang Y, Johnson K, Russell RG, et al. Association of sporadic chondrocalcinosis with a −4-basepair G-to-a transition in the 5′-untranslated region of ANKH that promotes enhanced expression of ANKH protein and excess generation of extracellular inorganic pyrophosphate. Arthritis Rheum. 2005;52:1110–7.
Zhang Y, Terkeltaub R, Nevitt M, et al. Lower prevalence of chondrocalcinosis in Chinese subjects in Beijing than in white subjects in the United States: the Beijing osteoarthritis study. Arthritis Rheum. 2006;54:3508–12.
Zitnan D, Sitaj S. Chondrocalcinosis polyarticularis (familiaris): roentgenological and clinical analysis. Cesk Rentgenol. 1960;14:27–34.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Rosenthal, A.K., Andres, M., Abhishek, A., Terkeltaub, R. (2023). CPPD and Other Microcrystalline Disorders. In: Stone, J.H. (eds) A Clinician's Pearls & Myths in Rheumatology. Springer, Cham. https://doi.org/10.1007/978-3-031-23488-0_37
Download citation
DOI: https://doi.org/10.1007/978-3-031-23488-0_37
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-23487-3
Online ISBN: 978-3-031-23488-0
eBook Packages: MedicineMedicine (R0)